Volume 20, Issue 2 (7-2006)                   Med J Islam Repub Iran 2006 | Back to browse issues page

XML Print


, hourirezvan@yahoo.com
Abstract:   (4957 Views)

   ABSTRACT

  Human blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood transfusion. In this article various measures and technologies that can be applied in order to reduce the residual risk are reviewed.

Full-Text [PDF 134 kb]   (1893 Downloads)    
Type of Study: Original Research | Subject: Immunology

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.